Journal of Ayurveda and Integrated Medical Sciences

2025 Volume 10 Number 7 JULY
Publisherwww.maharshicharaka.in

A Critical Review on Safe Handling of Vegetable Origin Drugs used in Ayurveda from Schedule (E1) of the Drugs and Cosmetics Rules, 1945

Rachna1*, Ritu2, Tomar BS3, Chawla SK4
DOI:10.21760/jaims.10.7.18

1* Rachna, Post Graduate Scholar, Dept of Agada Tantra Evam Vidhi Vaidyaka, Institute for Ayurved Studies and Research, Shri Krishna AYUSH University, Kurukshetra, Haryana, India.

2 Ritu, Assistant Professor, Dept of Kaumarbhritya, Glocal College Ayurvedic Medical Sciences and Research Centre, Saharanpur, Uttar Pradesh, India.

3 Brijendra Singh Tomar, HOD and Professor, Dept of Agada Tantra Evam Vidhi Vaidyaka, Institute for Ayurved Studies and Research, Shri Krishna AYUSH University, Kurukshetra, Haryana, India.

4 Satbir Kumar Chawla, Associate Professor, Dept of Agada Tantra Evam Vidhi Vaidyaka, Institute for Ayurved Studies and Research, Shri Krishna AYUSH University, Kurukshetra, Haryana, India.

Introduction: The Drugs and Cosmetics Rules, 1945 were established by the Government of India under the authority of the Drugs and Cosmetics Act, 1940. This Act is designed to ensure that drugs and cosmetics sold in India meet standards for quality, safety, and effectiveness. Schedule (E1) of these rules identifies poisonous substances of plant origin that are used in the Ayurvedic, Siddha and Unani systems of medicine. The focus of the present work is on the safe handling and use of plant origin poisonous drugs used in Ayurvedic system of medicine.

Methodology: A thorough evaluation of literature was done, including the relevant portions of the Drugs and Cosmetics Rules, 1945, authoritative text books of Ayurveda, published research papers in reputed journals.

Results: The Drugs and Cosmetics Rules, 1945, which mandates that ASU drugs in which the Ayurvedic system classifies fourteen medications with vegetable origins under the category of poisonous substances. Despite being part of the Visha-Upavisha which is a category of poisonous substances, these medications are not hazardous because Ayurveda recommends a special method of cleansing called Shodhana before utilizing them for therapeutic purposes. Schedule E (1) of the Drugs and Cosmetics Rules, 1945, is associated with Rule 161(2).

Conclusion: Ayurvedic drug manufacturers, dealers, Vaidya and physicians must be aware and focus on the safe manufacturing practices of medicines, rational prescription and safe dosage of medicines and sale of such medicines should be done only under the valid prescription. By ensuring appropriate information to patients regarding the dosage and administration.

Keywords: Visha-Upavisha Varga, Poisonous drugs, Schedule (E1), Drugs and Cosmetic Rules 1945

Corresponding Author How to Cite this Article To Browse
Rachna, Post Graduate Scholar, Dept of Agada Tantra Evam Vidhi Vaidyaka, Institute for Ayurved Studies and Research, Shri Krishna AYUSH University, Kurukshetra, Haryana, India.
Email:
Rachna, Ritu, Tomar BS, Chawla SK, A Critical Review on Safe Handling of Vegetable Origin Drugs used in Ayurveda from Schedule (E1) of the Drugs and Cosmetics Rules, 1945. J Ayu Int Med Sci. 2025;10(7):121-128.
Available From
https://jaims.in/jaims/article/view/4520/

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2025-05-19 2025-05-29 2025-06-09 2025-06-19 2025-06-24
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
None Nil Not required 11.32

© 2025 by Rachna, Ritu, Tomar BS, Chawla SK and Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

Download PDFBack To ArticleIntroductionMaterials and MethodsDiscussionConclusionReferences

Introduction

The AYUSH system encompasses traditional and alternative healthcare practices such as Ayurveda, Yoga, Naturopathy, Unani, Siddha, Sowa-Rigpa, and Homeopathy.[1] To foster the growth and integration of these systems, the Government of India has launched various initiatives. A primary focus has been ensuring the quality, safety, and efficacy of AYUSH medicines. To regulate the production, distribution, export, and research of these medicines, the government has enacted several laws and regulations, including the Drugs and Cosmetics Act of 1940 and the Drugs and Cosmetics Rules of 1945.[2] These legal frameworks establish standards for manufacturing practices, quality control, and licensing requirements for AYUSH products. Additionally, the Ministry of AYUSH has implemented Good Manufacturing Practices (GMP) guidelines under Schedule T of the Drugs and Cosmetics Act to ensure hygienic conditions and quality assurance in the production of Ayurvedic, Siddha, and Unani medicines.[3] In addition, monitoring and the safety of AYUSH medicines post-marketing, a pharmacovigilance program was launched to collect and analyse data on adverse drug reactions, thereby enhancing patient safety. Drugs and Cosmetics Act, 1940, Drugs and Cosmetics Rules, 1945. There are several schedules to these rules among of them schedule (E1) describes the list of poisonous substances under the ASU medicine.

Schedule E1, as delineated in Rule 161(2) of the Drugs and Cosmetics Rules, 1945, is a critical component of India's regulatory framework governing the use of certain potent substances in traditional medicine systems. This schedule enumerates specific drugs of plant, animal, and mineral origin utilized in Ayurvedic, Siddha, and Unani (ASU) practices, which are classified as poisonous and thus necessitate stringent controls to ensure public safety.

Materials and Methods

Through literature searches about relevant portions of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945, and published research papers related to the topic that are available online in databases like PubMed, Google Scholar etc were collected and reviewed.

Details regarding the plant origin drugs mentioned in the Schedule (E1) were reviewed from the authoritative text books of Ayurveda like Samhitas, API, AFI, various books of Dravyaguna Vigyan etc.

Composition of Schedule E1 in Ayurveda[4,5]

According to the notification (G.O.I. Notification No. 1-23/67-D dated 2-2-1970), the Ayurvedic system includes:

  • Plant-Origin Substances (15): Ahipena (Papaver somniferum), Arka (Calotropis gigantea), Bhallataka (Semecarpus anacardium), Bhanga (Cannabis sativa), Danti (Baliospermum montanum), Dhattura (Datura metel), Gunja (Abrus precatorius), Jaipala (Croton tiglium), Karaveera (Nerium indicum), Langali (Gloriosa superba), Parasika Yavani (Hyoscyamus niger), Snuhi (Euphorbia nerifolia), Vatsanabha (Aconitum ferox), Vishamushti (Strychnos nux-vomica), and Shringivisha (Aconitum chasmanthum).
  • Animal-Origin Substance (1): Sarpa Visha (Snake venom).
  • Mineral-Origin Substances (9): Hartala (Arsenic trisulfide), Gauripashana (Arsenic), Parada (Mercury), Manahshila (Arsenic disulfide), Tuttha (Copper sulfate), Rasa Karpura (Mercurous chloride), Sindura (Red oxide of lead), Hingula (Cinnabar), and Girisindura (Red oxide of mercury).

Over time, the Indian government has updated the list of potentially toxic substances used in Ayurvedic medicine, known as Schedule E1 under the Drugs and Cosmetics Rules, 1945. These changes aim to enhance patient safety by refining which parts of certain plants are considered harmful. Schedule (E1) pertains to the 1945 Drugs and Cosmetics Rules, Rule 161(2).

This Schedule lists the poisonous substances employed in ASU systems, together with information about their scientific name, specific toxic component, and source (vegetable, animal, or mineral).

Prior to 1982, the Schedule was referred to as Schedule (E), which was removed. In 2010, it was replaced by Schedule (E1) with new modifications (G.S.R. 683 (E) dated 19-08-2010).[6] The following are the changes made to the Ayurvedic medical system's list of toxic substances.


For instance, Snuhi (Euphorbia nerifolia) was removed from the list, indicating it's no longer classified as a poisonous plant in this context. Additionally, the seeds of Ahipena (Papaver somniferum) and Bhanga (Cannabis sativa) were exempted, suggesting that these parts are deemed less risky. Conversely, for Gunja (Abrus precatorius) and Jaipala (Croton tiglium), only the seeds were included in the list, highlighting that these specific parts are particularly toxic.[7] These revisions aim at establishing a balance between patient safety and the therapeutic advantages of Ayurvedic medications, reflecting an increasing awareness of the toxic effects of various plant parts.

Table 1: List of poisonous substances in Vegetable origin under Ayurvedic Systems of Medicine included in Schedule (E1)

I. Drugs of vegetable origin[6]
1.  Ahipena (Except seeds)Papaver somniferum Linn
2.  ArkaCalotropis procera (Ait.) R. Br.
3.  BhallatakaSemecarpus anacardium Linn.f.
4.  Bhanga (Except seeds)Cannabis sativa Linn. (Except seeds)
5.  DantiBaliospermum montanum Mull. Arg.
6.  DhatturaDatura metel Linn
7.  Gunja (seed)Abrus precatorius Linn. (seed)
8.  Jayapala (seed)Croton tiglium Linn.
9.  KaraveeraNerium indicum Mill.
10. LangaliGloriosa superba Linn.
11. Parasika yavaniHyoscyamus niger Linn.
12. VatsanabhaAcontium chasmanthum Stapf ex Holmes.
13. VishamushtiStrychnos nux-vomica Linn.
14. ShringivishaAcontium chasmanthum Stapf ex Holmes
II. Drugs of Animal Origin
15. Sarpa VishaSnake poison
III. Drugs of Mineral Origin
16. GauripaashanaArsenic
17. HaritalaArseno sulphide
18. ManashilaArseno sulphide
19. ParadaMercury
20. Rasa KarpuraHydrargyri subchloridum
21. TutthaCopper sulphate
22. HingulaCinnabar

Substances listed under Schedule E1 of the Drugs and Cosmetics Rules, 1945, must comply with specific safety regulations to ensure they are used properly and safely. These medicines must carry a clear warning label that states: “Caution: To be taken under medical supervision,” in both English and Hindi, as required by Rule 161(2).[8]

They should only be used under the supervision of a qualified healthcare professional, as the ingredients in Schedule E1 can be very potent and may lead to harmful effects if misused. In Ayurvedic practice, such substances are first purified through a traditional process called Shodhana. This purification reduces their toxicity and enhances their healing properties, with different methods used depending on the specific substance.[9]

By ensuring correct labeling, professional supervision, and proper purification, these potent ingredients can be used safely and effectively in traditional medicine.

Toxicity profile of plant origin Ayurvedic formulations listed under Schedule (E1).

Ayurvedic literature classifies poisonous drugs into two categories: Visha and Upavisha, based on their potency and lethality.[10] Visha substances are highly toxic and potentially lethal, whereas Upavisha substances are less toxic but still capable of causing harmful effects. Among the plant-based drugs listed under Schedule (E1) in Ayurveda, Vatsanabha and Shringivisha are classified as Visha due to their high toxicity. In contrast, Ahiphena, Arka, Bhallataka, Bhanga, Dhattura, Gunja, Jayapala, Karaveera, Langali and Vishamushti fall under the Upavisha category, as they are less potent but still produce toxic symptoms. The Visha (poisonous) character of Danti and Parasika Yavani is not mentioned in Ayurvedic texts. However, Danti is one of the Moolini Dravyas (useful medicines of which roots are beneficial) and has Tikshna, Ushna, Vikashi, and Aasukari qualities[11] that are comparable to those of Visha (poison).[12]

Additionally, before using Danti in formulations, its Samskara (processing) is specified in order to eliminate its Vikashi virtue.[11] Tropane alkaloids make Parasika Yavani toxic, and excessive levels of it can have major adverse impacts.[13]

Pharmacological activities of plant origin Ayurvedic drugs in Schedule (E1)

  • All the vegetable origin drugs mentioned in Schedule (E1) are extensively used in therapeutics by Ayurvedic system of medicine.[14] While looking into the pharmacological properties, all the drugs have Tikshna-Ushna Guna, Katu Rasa and very few have shown Prabhava (special effect).


  • Being grouped under Visha-Upavisha category, all are fast acting (Asukari), as Sukshma and Yogavahi, which in turn helps to exhibit the therapeutic action in very small doses.
  • Screening of formulations which commonly practised by Ayurvedic practitioners reveal the extensive use of Visha and Upavisha
  • Nearly 160 formulations are mentioned in the Ayurveda formulary of India and about 430 formulations in Bhaishajya Ratnavali.[15]

Table 2: Method of Shodhana (Purification), Dosage & Important formulations of plant origin Ayurvedic drugs in Schedule (E1)

SNDrugs of Vegetable Origin and chemical composition [16-19]Method of Sodhana (Purification)[20]Therapeutic Dose[21]Formulations[16,18]
1.Ahipena (Except seeds)
Chemical Composition: Opium alkaloids are isoquinoline alkaloids- morphine, codeine, narcotine, papaverine, heroin
21 times Bhavana in Shringavera (Ardraka) Swarasa30-125mgAhiphenasav, Ashtakshari Gutika, Akarakarabhadi Vati, Nidrodaya Rasa
2.Arka
Chemical Composition: Glycosides – Calotropin (more toxic than Strychnine), calotoxin
To purify Arka Ksheera, Tila (Sesamum indicum Linn.) is fried and put into it. Either 2 or 3 among the following combination of Ela, Maricha, Nagahwa & Pippali is fried and put into Arka Ksheera. Arka Ksheera is Sudha (pure) by itself. Also, same Shodhana Vidhi (Purification method) as that of Snuhi Ksheera (Euphorbia neriifolia Linn.) can be applied.Root for decoction 1-3gm Leaf Churna- 250-750 mg Stem bark Churna- 0.5-1 gm Kshira[17] - ¼ - ¾ gmArka Lavana, Arka Ksheeradi Lepa
3.Bhallataka
Chemical Composition:
Anacardic acid, nonvolatile alcohol (cardol), bhilawanol, anacardoside
Take Bhallātaka, remove the attached thalamus and soak in Gomūtra for 7 days. Replace Gomūtra every 24 h with fresh Gomūtra. After 7 days, rinse the Bhallātaka twice with water, to wash off the Gomūtra. Soak Bhallātaka in Godugdha for 7 days, replacing Godugdha every 24 h with fresh Godugdha. After 7 days, rinse the Bhallātaka 2 or 3 times with water to wash off the Godugdha. Put the Bhallātaka in a thick jute bag containing coarse brick powder and rub carefully, with a view to reduce the oil content in Bhallātaka. Wash the processed seed with water and dry.1.2gm of drug in Kshirapaka form
Oil- 10-20 drops
Amrita Bhallataka Leha, Bhallataka Rasayana, Sanjivani Vati, Guggulutiktaka Ghrita
4.Bhanga (Except seeds)
Chemical Composition: Major active euphoric principle is tetrahydrocannabinol (THC), cannabinoids, volatile terpenes and sesquiterpenes
Vijaya put in a muslin bag and wash in water till free from turbidity and then dry.Churna- 125- 250mgJatiphaladi Churna, Madanaananda Modaka Trailokya Vijaya Vati
5.Danti
Chemical Composition:
Triterpenoids, resinous glycosides, phorbol esters, steroids, saponins, alkaloids, flavonoids
Roots of Danti are smeared with the paste of Pippali (Piper longum Linn.) and Madhu (honey); and wrapped with the leaves of Kusha (Desmostachya bipinnata Stapf.) and then coated with mud and Putapaka Swedana is done. After that roots are separated and dried under sunlight. This process reduces the Vikashi property of Danti.Churna- 1-3 gmAbhayarishta, Dantyarishta, Kankayana Gutika, Dantiharitaki, Kaisora Guggulu, Punarnava Mandura
6.Dhattura
Chemical Composition:
Tropane alkaloids Hyoscine (Scopolamine) is the major constituent, while atropine and l hyoscyamine is very less in quantity.
Seeds are soaked in Gomutra for 12 hours. Wash with water and then subject to Dola Yantra Swedana with Godugdha for one Yama (3 hours). Then remove the testa and can be used.100-200mgKanakasava, Ekangavira Rasa, Tribhuvanakirti Rasa, Laghu Vishagarbha Taila
7.Gunja (Seeds)
Chemical Composition: Abrin, hypaphorine, precatorine, glycyrrhizin, choline
Dola Yantra Swedana with Kanjika for one Yama (3 hours). Remove the outer cover, wash and dry.Churna- 60- 180mgMritasanjivani Gutika, Gunjabhadra Rasa


8.Jayapala (Seeds)
Chemical Composition:
Crotonoside (isoguanosine), Crotonoleic acid, Glyceryl crotonate, Phorbol esters
Remove testa of Jayapala seeds and subject to Dola Yantra Swedana with Godugdha for 3 hours. Then remove the embryo of the seed, dry the cotyledons and powder. Next Bhavana is to be done with Nimbu Swarasa for 3 days. After that dry in sun.Churna- 6-12mgIchabhedi Rasa, Jalodarari Rasa, Mahajwarankusa Rasa, Sukhavirechana Vati
9.Karaveera
Chemical Composition:
Cardiac Glycosides- Oleandrin, oleandrigenin
Dola Yantra Swedana with Godugdha for 2 hours.Churna- 30- 125mgBrihanmarichadya Taila, Karaviradya Taila
10.Langali
Chemical Composition:
Amino alkaloids (Proto-alkaloids) Colchicine
Soak small pieces of Langali Mula in Gomutra for 24 hours, then wash and dry.125-250mgNirgundi Taila, Mahavishagarbha Taila, Kalakuta Rasa, Kasisadi Tail
11.Parasika Yavani
Chemical Composition:
tropane alkaloids- hyoscyamine is the major constituent, while atropine and hyoscine are very less in quantity
--125-500mgSarpagandhaghna Vati
12.Vatsanabha
Chemical Composition:
Alkaloids- Aconitine, Indaconitine, Chasmaconitine,Chasmathinine, bikhaconitine
Small pieces of Vatsanabha are bundled in clean muslin cloth, soak in Gomutra for three days and kept under sunlight, replacing the latter every day. Then wash and dry.Churna- 15-30mgTribhuvanakirti Rasa, Anandabhairava Rasa, Sutasekhara Rasa, Hinguleswara Rasa, Mrityunjaya Rasa, Mahavatavidhwamsa Rasa
13.Vishamushti
Chemical Composition:
Bitter indole alkaloids Strychnine, Brucine Glycoside (Loganin), Vomicine
Vishamushti (Kupilu) is kept in Gomutra for 7 days. Fresh Gomutra is to be replaced every day. Thereafter it is removed and washed with water. Then Swedana in Godugdha with Dola Yantra for 3 hours is done. The testa and embryo are removed, the cotyledon is roasted in ghee and powdered well.Churna- 60- 125mgLakshmivilasa Rasa, Ekangavira Rasa, Karaskara Ghrita
14.Shringivisha
Chemical Composition: Alkaloids- Aconitine, Indaconitine, Chasmaconitin, Chasmathinine, bikhaconitine
Small pieces of root are bundled in clean muslin cloth, and soak in Gomūtra for three days, replacing the latter every day. Then wash and dry.Churna- 15-30mgTribhuvanakirti Rasa, Anandabhairava Rasa, Sutasekhara Rasa, Hinguleswara Rasa, Mahavatavidhwamsa Rasa

Discussion

The Drugs and Cosmetics Rules, 1945, which mandates that if an ASU medication contains any Schedule (E1) drug as an ingredient, a caution remark alerting the consumer to the fact that the medication should only be taken under medical supervision. Poisonous substances in vegetable origin serves as a crucial regulatory tool to ensure that potent substances used in traditional medicine systems are handled with the necessary caution, balancing their therapeutic potential against the imperative of patient safety. Despite their classification as poisonous, Schedule E1 substances have been traditionally employed for their medicinal properties.

According to Acharya Charaka, even a potent poison can act as best medicine if administered properly.[22] Shodhana is the Samskara of a toxic drug which convert it into non-toxic, which renders its therapeutic use. The aim of Shodhana procedure is to optimize the safety and efficacy of the raw drug before using it therapeutically. Studies have shown that the toxic constituents are transferred into media rendering the drug nontoxic.[23]

In addition to Shodhana, Ayurveda propose additional pharmacovigilance by emphasizing the importance of Yukti (logical reasoning) in treatment.[24] Acharya Charaka says that all Dravyas (substances) in this universe are medicinal if used in accordance to Yukti.


It is mentioned as one among the Paradi/Chikitsopayogi Gunas (qualities useful for treatment).[25] Application of this Yukti can be seen while analysing different Ayurvedic formulations. Some recent studies have explored their potential anti-cancer activities, suggesting that, when properly processed and administered, these substances may offer therapeutic benefits in oncology.[26]

For ASU Medicine, rule 161(2) mentioned that ‘The container of a medicine for internal use made up ready for the treatment of human ailments shall, if it is made up from a substance specified in Schedule (E1), be labelled conspicuously with the words Caution: To be taken under medical supervision both in English and Hindi language’.[27]

Meanwhile part XVII of the Drugs and Cosmetics Rules, 1945, Rule 161, addresses the labeling, packaging, and alcohol limit of Ayurvedic (including Siddha) or Unani medications. ASU medications that contain substances listed in Schedule (E1) as an ingredient can only be used with a prescription from a licensed healthcare professional also they should not be bought online or used without first consulting a doctor, according to Rule 161(2).[28]

Additionally, on July 14, 2022, the Central Consumer Protection Authority released an advisory about the sale of ASU medications on e-commerce platforms that contain substances listed in Schedule (E1) of the D&C Rules, 1945.[29]

Conclusion

Ayurvedic medicines are not toxic, as they are prepared only after proper Shodhana. Official books like API, AFI etc. also mentioned the purification procedure of Schedule E1 Drugs.

In the present scenario, Ayurvedic drug manufacturers, dealers, Vaidya and physicians must be aware and focus on the safe manufacturing practices of medicines, rational prescription and safe dosage of medicines and sale of such medicines should be done only under the valid prescription of an authorized physician, even in e-commerce platforms.

Physicians must ensure the safe usage of medicine by properly educating the patient regarding the dose and duration of administration of these medicines.

References

1. Taiyabi SF. AYUSH: An introduction [Internet]. Ministry of Ayush, Government of India. Available from: https://ayushnext. ayush.gov.in/detail/post/ayush [Crossref][PubMed][Google Scholar]

2. Ministry of Health and Family Welfare, Government of India. The Drugs and Cosmetics Act and Rules: Ayush drugs [Internet]. p. 6. Available from: [Article][Crossref][PubMed][Google Scholar]

3. Katiyar CK, Chakrabarty AK, Dubey SK, Pandey PK, Tumulu M, Narwaria A. Enhancing quality of AYUSH products: Strategies and efforts of the Ministry of AYUSH and AYUSH industry. J Res Ayurvedic Sci. 2023;7(Suppl 1):S73–81. Available from: [Article][Crossref][PubMed][Google Scholar]

4. Ministry of Health and Family Welfare, Government of India. Drugs and Cosmetics Act and Rules. 1940; Schedule E(1), Rule 161(2):317. . [Crossref][PubMed][Google Scholar]

5. Ministry of Health and Family Welfare, Government of India. Drugs and Cosmetics Act and Rules. 1945; Schedule E(1), Rule 161(2):300. . [Crossref][PubMed][Google Scholar]

6. Ministry of Health and Family Welfare, Government of India. The Drugs and Cosmetics Act and Rules: Ayush drugs [Internet]. p. 300. Available from: [Article][Crossref][PubMed][Google Scholar]

7. Ruknuddin, Galib. Recent amendments in D&C Act with reference to Ayurvedic drug industry. Souvenir on Arogyavardhini 2012: JSS Ayurveda Mahavidyalaya, Mysore. [Internet]. Available from: [Article][Crossref][PubMed][Google Scholar]

8. Ministry of Health and Family Welfare, Government of India. The Drugs and Cosmetics Act and Rules: Ayush drugs [Internet]. p. 190. Available from: [Article][Crossref][PubMed][Google Scholar]

9. Maurya SK, Seth A, Laloo D, Singh NK, Gautam DN, Singh AK. Śodhana: An Ayurvedic process for detoxification and modification of therapeutic activities of poisonous medicinal plants. Ancient Sci Life. 2015 Apr;34(4):188. [Crossref][PubMed][Google Scholar]

10. Sharma S. Vishopavishadi vijnaniya. In: Shastri K, editor. Rasatarangini. Varanasi: Motilal Banarasidas; 1979. p.647 [Crossref][PubMed][Google Scholar]


11. Agnivesha. Dantidravanti Kalpam. In: Acharya VJT, editor. Charaka Samhita revised by Charaka and Dridabala with Ayurveda Dipika commentary of Chakrapanidatta. Varanasi: Chaukhambha Orientalia; 2009. p.670 [Crossref][PubMed][Google Scholar]

12. Agnivesha. Deerghanjeeviteeyam. In: Acharya VJT, editor. Charaka Samhita revised by Charaka and Dridabala with Ayurveda Dipika commentary. Varanasi: Chaukhambha Orientalia; 2009. p.20 [Crossref][PubMed][Google Scholar]

13. Aparna K, Joshi AJ, Vyas M. Adverse reaction of Parasika Yavani (Hyoscyamus niger Linn): Two case study reports. Ayu. 2015 Apr;36(2):174. [Crossref][PubMed][Google Scholar]

14. Adhana RK, Chaudhry R. Clinical importance of Upavisha: A therapeutic portrayal of toxic drugs. World J Pharm Res [Internet]. 2019;8(7):1594–1606. Available from: [Article][Crossref][PubMed][Google Scholar]

15. Sumedhan V, Soumya MC, Sinimol TP. Review on Upavishas of clinical significance. J Ayurveda Integr Med Sci [Internet]. 2020 Feb 29;5(1):194–205. Available from: [Article][Crossref][PubMed][Google Scholar]

16. Ministry of Health and Family Welfare, Government of India. The Ayurvedic Pharmacopoeia of India. Part I [Internet]. Vols I–V. Available from: [Article][Crossref][PubMed][Google Scholar]

17. Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. 51st ed. Pune: Nirali Prakashan; 2015. p.14.122, 15.19, 15.39, 15.51, 15.54, 15.68 [Crossref][PubMed][Google Scholar]

18. Central Council for Research in Ayurveda & Siddha. Database on Medicinal Plants used in Ayurveda & Siddha. New Delhi: Dept. of AYUSH, Ministry of Health and Family Welfare; 2007. Vols 1–8 [Crossref][PubMed][Google Scholar]

19. Indian Council of Medical Research. Quality standards of Indian medicinal plants. New Delhi: ICMR; 2017. Vols 1–14. [Crossref][PubMed][Google Scholar]

20. Ministry of Health and Family Welfare, Govt. of India. The Ayurvedic Formulary of India. Part I. Appendix II. 2nd revised English ed. 2003. p.361–369 [Crossref][PubMed][Google Scholar]

21. Ministry of Health and Family Welfare, Govt. of India. The Ayurvedic Pharmacopoeia of India. Part I [Internet]. Vols I–V. Available from: [Article][Crossref][PubMed][Google Scholar]

22. Agnivesha. Deerghanjeeviteeyam. In: Acharya VJT, editor. Charaka Samhita revised by Charaka and Dridabala with Ayurveda Dipika commentary of Chakrapanidatta. Varanasi: Chaukhambha Orientalia; 2009. p.23 [Crossref][PubMed][Google Scholar]

23. Ilanchezhian R, Roshy JC, Acharya R. Importance of media in Shodhana (purification/processing) of poisonous herbal drugs. Ancient Sci Life. 2010 Oct;30(2):54. [Crossref][PubMed][Google Scholar]

24. Agnivesha. Atreyabhadrakapyeeyam. In: Acharya VJT, editor. Charaka Samhita revised by Charaka and Dridabala with Ayurveda Dipika commentary of Chakrapanidatta. Varanasi: Chaukhambha Orientalia; 2009. p.138 [Crossref][PubMed][Google Scholar]

25. Agnivesha. Atreyabhadrakapyeeyam. In: Acharya VJT, editor. Charaka Samhita revised by Charaka and Dridabala with Ayurveda Dipika commentary of Chakrapanidatta. Varanasi: Chaukhambha Orientalia; 2009. p.141 [Crossref][PubMed][Google Scholar]

26. Vikram ENT, Ilavarasan R, Kamaraj R. Anti-cancer activities of Schedule E1 drugs used in Ayurvedic formulations. J Ayurveda Integr Med. 2022 Apr–Jun;13(2):100545. doi: 10.1016/j.jaim.2022.100545. PMID: 35661925; PMCID: PMC9163510 [Crossref][PubMed][Google Scholar]

27. Ministry of Health and Family Welfare, Government of India. The Drugs and Cosmetics Act and Rules: Ayush drugs [Internet]. p. 190. Available from: [Article][Crossref][PubMed][Google Scholar]

28. Ministry of Ayush, Government of India. Public notice [Internet]. 2016 Feb 01. Available from: https://cdn. ayush.gov.in/wpcontent/uploads/2021/03/Public-Notice-in%20English.pdf [Crossref][PubMed][Google Scholar]


29. Ministry of Consumer Affairs, Government of India. Advisory concerning sale of Ayurveda, Siddha and Unani drugs [Internet]. 2022 Jul 14. Available from: https://affairs. nic.in/sites/default/files/fileuploads/latestnews/ADVISORYConserning%20sale%20of%20Ayurvedic%2C%20Siddha%20and%20Unani%20Drugs.pdf [Crossref][PubMed][Google Scholar]

Disclaimer / Publisher's Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of Journals and/or the editor(s). Journals and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.